Correlation Between Virpax Pharmaceuticals and Painreform
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Painreform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Painreform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Painreform, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Painreform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Painreform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Painreform.
Diversification Opportunities for Virpax Pharmaceuticals and Painreform
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virpax and Painreform is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Painreform in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Painreform and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Painreform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Painreform has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Painreform go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Painreform
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Painreform. But the stock apears to be less risky and, when comparing its historical volatility, Virpax Pharmaceuticals is 1.13 times less risky than Painreform. The stock trades about -0.16 of its potential returns per unit of risk. The Painreform is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 324.00 in Painreform on November 2, 2024 and sell it today you would earn a total of 7.00 from holding Painreform or generate 2.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Painreform
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Painreform |
Virpax Pharmaceuticals and Painreform Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Painreform
The main advantage of trading using opposite Virpax Pharmaceuticals and Painreform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Painreform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Painreform will offset losses from the drop in Painreform's long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Painreform vs. Regencell Bioscience Holdings | Painreform vs. Procaps Group SA | Painreform vs. Universe Pharmaceuticals | Painreform vs. Veritas Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |